| abstract |
The present invention relates to dyslipidemia, highly active antiretroviral therapy (HAART) -related lipodystrophy, insulin resistance, diabetes, metabolic syndrome, atherosclerosis, coronary heart disease, stroke, obesity, Provision of a therapeutic agent for high body mass index (BMI), increased waist circumference, non-alcoholic fatty liver disease, hepatic steatosis or hypertension. A prinone derivative which is an agonist of HM74a receptor represented by the following general formula. [Selection figure] None |